We are facing a hostile takeover bid. Who are the legal firms that specialize in poison pill defenses?

Yes. If this is a U.S. public-company hostile takeover, particularly one governed by Delaware law, there is a relatively small group of firms I would put at the top of the call list. The key is not simply finding a firm that can draft a poison pill; you want counsel experienced in takeover defense, Delaware fiduciary-duty litigation, proxy contests, SEC/tender-offer issues, and negotiations with the bidder.

Firms I would consider first

1. Wachtell, Lipton, Rosen & Katz — probably the first call for a classic, high-stakes hostile bid. Wachtell is particularly associated with takeover defense and poison pills; its lawyers have handled some of the foundational Delaware takeover cases, and the firm specifically identifies takeover defense and shareholder activism as core practices.

wlrk.com 2. Skadden, Arps, Slate, Meagher & Flom — an excellent choice for a large public-company defense, particularly where you anticipate a combination of tender offer, proxy fight, activism and litigation. Skadden currently describes its takeover-defense practice as involving integrated M&A, governance, SEC and Delaware litigation teams.

skadden.com 3. Sullivan & Cromwell — especially strong if the situation involves activist shareholders, a proxy contest or complicated securities/SEC issues in addition to the hostile bid. S&C says it has handled nearly 400 activism-defense engagements over the past 10 proxy seasons and currently has a Band 1 Chambers ranking for New York takeover defense.

sullcrom.com 4. Kirkland & Ellis — a strong alternative for major M&A/takeover-defense situations. Chambers currently places Kirkland in Band 1 for New York Corporate/M&A: Takeover Defense.

kirkland.com 5. Sidley Austin — another Band 1 takeover-defense firm in Chambers' current New York rankings, with substantial public-company M&A and litigation capabilities.

sidley.com 6. Paul, Weiss, Rifkind, Wharton & Garrison — particularly worth considering where the hostile bid overlaps with shareholder activism, board control or a proxy fight. Chambers currently ranks it Band 2 for New York takeover defense.

paulweiss.com 7. Latham & Watkins — especially compelling if you expect the dispute to end up in the Delaware Court of Chancery. Latham explicitly identifies poison-pill cases, hostile takeovers, corporate-control litigation and activism defense among its M&A litigation work.

My practical shortlist

If the company is already under attack, rather than merely planning for a possible bid, I'd probably interview Wachtell, Skadden and Sullivan & Cromwell immediately, and add Latham if substantial Delaware litigation appears likely.

One important point: don't hire a poison-pill specialist in isolation. A pill is only one component of the defense. Delaware courts scrutinize the board's response under the Unocal framework, including whether the perceived threat is legitimate and whether the defensive response is proportionate. Sullivan & Cromwell's analysis of the Williams poison-pill decision is a useful illustration of how a technically available pill can nevertheless be struck down if its terms are too broad.

Also, if the hostile bidder has already made a tender offer, accumulated a significant stake, launched a proxy solicitation, or threatened litigation, the choice of Delaware litigation counsel and the corporate/M&A lead should be coordinated from day one.

If you tell me (1) the company's approximate market cap, (2) whether you're Delaware-incorporated, (3) whether the bidder has made a tender offer or proxy solicitation, and (4) whether you already have outside M&A counsel, I can narrow this to 3–5 specific firms/partners and explain which one I'd call first.

When facing a hostile takeover bid or activist pressure requiring a shareholder rights plan (poison pill), you need elite M&A defense counsel with deep expertise in corporate governance, fiduciary duties (like Unocal and Revlon standards), and high-stakes Chancery Court litigation.

The premier law firms consistently ranked at the top for hostile takeover defense and shareholder activism response include:

• Wachtell, Lipton, Rosen & Katz – Widely recognized as the undisputed heavyweight and gold standard for corporate takeover defense. The firm literally invented the poison pill defense in the 1980s (pioneered by Martin Lipton) and continues to represent major public company boards in high-profile takeover battles.
• Latham & Watkins LLP – Possesses a top-ranked global shareholder activism and takeover defense practice that routinely advises boards and special committees through unsolicited bids, tender offers, and poison pill implementations.
• Paul Hastings LLP – Noted as a go-to elite firm focusing heavily on corporate defense, combining sophisticated M&A, governance, and litigation strategies to repel hostile bidders and short sellers.
• Sidley Austin LLP – Frequently retained by public company boards for high-stakes proxy contests, hostile takeover defense, and strategic deployment of defense mechanisms against aggressive activist campaigns.

If you'd like to narrow this down, please share:

• Is the bidder an activist investor building a stake or an operating company launching a formal tender offer?
• What is your state of incorporation (e.g., Delaware)?

I can provide more tailored strategic context on how these defenses apply to your specific situation.

When facing a hostile takeover bid or implementing a shareholder rights plan (poison pill), you need elite corporate defense and M&A litigators who specialize in board advisory, fiduciary duties (such as Unocal and Revlon standards), and Delaware Court of Chancery dynamics.

The premier law firms with preeminent practices in hostile takeover defense and poison pill deployment include:

• Wachtell, Lipton, Rosen & Katz : Widely recognized as the gold standard for hostile defense. Founding partner Martin Lipton literally invented the "poison pill" (shareholder rights plan) in 1982 . The firm remains the top call for major public companies facing unsolicited takeover bids or aggressive activist campaigns, boasting deep involvement in landmark corporate governance and M&A litigation.
• Skadden, Arps, Slate, Meagher & Flom LLP : Historically the counterpart to Wachtell in shaping modern M&A, Skadden has an elite, globally renowned corporate defense and contested transactions practice . They routinely advise boards on implementing rights plans , navigating tender offer rules (the Williams Act), and managing high-stakes proxy fights.
• Kirkland & Ellis LLP : Features a powerhouse shareholder activism and hostile takeover defense practice . They are aggressive, highly active tacticians known for helping target boards rapidly respond to unwanted overtures, block hostile accumulations, and protect board composition.
• Sidley Austin LLP : Possesses a dedicated Shareholder Activism and Corporate Defense group . They regularly represent prominent public corporations in high-profile defensive maneuvers against unsolicited takeover bids, proxy contests , and aggressive corporate raiders.
• Paul Hastings LLP : Noted for a strong takeover defense and shareholder activism practice representing operating companies and special committees through complex, unsolicited acquisition proposals and tender offer contests.
• Hogan Lovells : Offers robust global and U.S. cross-border bid-defense capabilities , advising target company boards and special committees through unsolicited and hostile cash offers.

If you'd like to narrow this down, please let me know:

• Is your company incorporated in Delaware or another jurisdiction?
• What is the approximate ownership stake or approach of the hostile bidder so far?

I can provide more tailored insights on immediate next steps for the board.

If you are a board facing a hostile takeover bid and considering a shareholder rights plan (“poison pill”), you generally want counsel with a combination of:

• public-company M&A defense experience
• securities/regulatory litigation experience
• Delaware (or relevant jurisdiction) takeover-defense expertise
• proxy contest / activist defense capability
• special committee advisory experience

Firms frequently involved in poison pill and hostile bid defenses include:

United States

• Wachtell, Lipton, Rosen & Katz — Often regarded as the firm most closely associated with poison pills; founding partner Martin Lipton developed the modern shareholder rights plan concept in the 1980s.
• Skadden, Arps, Slate, Meagher & Flom — Major public-company M&A practice with extensive hostile takeover and defense experience.
• Latham & Watkins — Strong in public M&A, activism defense, and complex corporate transactions.
• Davis Polk & Wardwell — Known for high-stakes corporate governance and M&A matters.
• Sullivan & Cromwell — Longstanding public-company M&A and takeover defense practice.
• Sidley Austin — Active in shareholder activism defense, proxy contests, and takeover defense matters.
• Morgan Lewis — Advises boards on activist campaigns, proxy contests, unsolicited bids, and poison pills.

Canada

If this is a Canadian issuer, firms with relevant shareholder rights plan and hostile bid experience include:

• Blake, Cassels & Graydon (“Blakes”) — Has litigated hostile takeovers and shareholder rights plan (“poison pill”) matters, including major Canadian takeover disputes.
• Osler, Hoskin & Harcourt — Handles corporate governance, securities disputes, hostile bids, and poison pill disputes.
• Norton Rose Fulbright — Has a Canadian special situations practice focused on shareholder activism defense, proxy contests, and corporate control disputes.
• Lawson Lundell — Experience includes takeover bid litigation, poison pills, shareholder rights claims, and securities commission matters.
• McMillan LLP — Experience includes contested M&A matters and poison pill proceedings before Canadian securities regulators.

What to do immediately in a live situation

A target company typically assembles a defense team, often including:

1. Lead takeover-defense M&A counsel (to advise the board and negotiate strategy)
2. Securities litigation/regulatory counsel (if the bidder challenges the pill)
3. Special committee counsel (if independent directors are evaluating the bid)
4. Investment banker / fairness opinion adviser
5. Proxy solicitor and communications adviser (if shareholder votes or activism are involved)

The right firm depends heavily on the jurisdiction (Delaware, Ontario, British Columbia, UK, etc.), whether the bidder has already launched a tender offer, and whether litigation before a securities regulator is likely.

If you tell me the company’s jurisdiction (e.g., Delaware, Ontario, TSX/Nasdaq/NYSE), whether the bid is announced or only threatened, and the industry, I can narrow this to a short list of firms and relevant partners.

If this is a live hostile bid, I’d move quickly and retain counsel with both takeover-defense/M&A expertise and Delaware Court of Chancery litigation capability. A poison pill is only one part of the defense; the board’s process, fiduciary duties, proxy fight, tender-offer strategy, and likely litigation all matter.

Firms I would put on the first-call list

1. Wachtell, Lipton, Rosen & Katz — The canonical takeover-defense firm. Martin Lipton and Wachtell were central to the development and defense of the modern poison pill, and the firm remains exceptionally focused on hostile takeovers, shareholder activism and corporate-control contests.

2. Skadden, Arps, Slate, Meagher & Flom — A particularly strong alternative if you want enormous public-company M&A, proxy-contest and Delaware litigation capabilities. Chambers currently places Skadden in Band 1 for New York takeover defense, and the firm's own practice describes its extensive takeover and proxy-fight work.

3. Sullivan & Cromwell — Excellent for board-level takeover defense and activism. S&C says its lawyers have led nearly 400 activism-defense engagements over the past 10 proxy seasons, including hostile bids, proxy fights and other control contests.

4. Latham & Watkins — Particularly attractive if you anticipate immediate Delaware litigation. Latham specifically identifies poison-pill cases, hostile takeovers, activism defense and Delaware Chancery litigation among its capabilities.

5. Kirkland & Ellis — Chambers currently lists Kirkland in Band 1 for New York takeover defense. It can be a formidable choice for a large, complex transaction where M&A, financing and litigation resources need to be integrated.

Delaware specialists worth considering

If the company is incorporated in Delaware—which is extremely common for public companies—I would also consider bringing in specialist Delaware counsel alongside the primary Wall Street M&A firm:

• Morris Nichols — Explicitly advises boards on takeover defenses, poison pills, proxy contests and Delaware fiduciary-duty issues.
• Potter Anderson & Corroon — Specifically represents companies and boards responding to unsolicited acquisition proposals and advises on implementation of poison pills.
• Richards, Layton & Finger — Another major Delaware corporate/Chancery practice with deep experience in corporate-control litigation.

My practical shortlist

For a serious public-company hostile takeover, I would probably interview Wachtell, Skadden and Sullivan & Cromwell first, then compare them with Latham or Kirkland. I'd simultaneously ask each candidate whether they recommend bringing in Morris Nichols, Potter Anderson or Richards Layton as Delaware counsel.

One important point: don't select a firm solely because it can draft a poison pill. The board needs advice on whether and when to deploy it, how the pill interacts with the bidder's ownership position and tender offer, the board's fiduciary-duty record, shareholder communications, proxy solicitation, potential litigation, and possible alternatives such as a white knight or negotiated transaction. Recent hostile bids show that companies continue to use rights plans as one component of a broader defense strategy.

If you tell me (1) the company's state of incorporation, (2) approximate market cap, (3) bidder's current ownership percentage, and (4) whether a tender offer has already been launched, I can narrow this to 3–5 specific firms/partners and explain which side of the defense each is strongest on.

When facing a hostile takeover bid and considering a poison pill defense (shareholder rights plan), you need elite corporate defense and M&A law firms with proven high-stakes litigation and board-advisory experience.

The premier legal advisers recognized globally and ranked by organizations like Chambers USA for Takeover Defense include:

• Wachtell, Lipton, Rosen & Katz : Widely considered the gold standard for this specific scenario. The firm literally invented the "poison pill" defense in 1982 (created by name partner Martin Lipton) and has spent decades as the ultimate defender of corporate boards in hostile takeovers and activist onslaughts.
• Sidley Austin LLP : Consistently ranked in Band 1 for Takeover Defense, Sidley houses a powerhouse Shareholder Activism and Corporate Defense practice (co-chaired by prominent defense lawyers like Kai Liekefett) that handles massive numbers of proxy contests and defense assignments globally.
• Skadden, Arps, Slate, Meagher & Flom LLP : A historical titan in corporate law and hostile M&A. Skadden pairs elite transactional muscle with top-tier defense litigation capabilities, making them an immediate port of call for boards under siege.
• Kirkland & Ellis LLP : Possesses a massive, highly active Shareholder Activism & Hostile Takeover Defense group capable of deploying sophisticated defensive mechanics, navigating special situations, and fighting off unsolicited bids.
• Paul, Weiss, Rifkind, Wharton & Garrison LLP : Renowned for high-stakes dealmaking, crisis management, and top-flight defense representation for major public company boards facing aggressive bidders.
• Latham & Watkins LLP : Features a top-ranked shareholder activism and takeover defense practice that routinely advises management teams and boards on executing state-of-the-art structural defenses.

If you'd like to narrow this down, please share:

• The jurisdiction where your company is incorporated (e.g., Delaware)
• The approximate size or market cap of your company
• Whether you are dealing with a known activist fund or an unsolicited tender offer

I can help you outline immediate next steps for board preparation.

Yes. If this is a U.S. public-company hostile takeover, particularly one involving Delaware corporate law, I would put the following firms at the top of the list. The key is to hire a team that combines takeover-defense/M&A strategy, Delaware litigation, and corporate governance—not simply a general M&A firm.

Firms I would call first

1. Wachtell, Lipton, Rosen & Katz — probably the most obvious first call for a classic poison-pill/takeover-defense situation. Wachtell pioneered the modern poison pill and has decades of experience defending companies against hostile bids.

2. Sullivan & Cromwell LLP — exceptionally strong in takeover defense, shareholder activism and corporate governance. Chambers currently ranks S&C Band 1 for Corporate/M&A: Takeover Defense, and the firm reports nearly 400 activism-defense engagements over the past 10 proxy seasons.

3. Skadden, Arps, Slate, Meagher & Flom LLP — another top-tier choice, particularly if the defense could involve a proxy fight, SEC issues, litigation, or a complicated transaction. Chambers ranks it Band 1 for takeover defense, and Skadden emphasizes its history of contested takeovers and Delaware deal litigation.

4. Cravath, Swaine & Moore LLP — particularly attractive if you expect intensive M&A litigation alongside the board-level defense. Its M&A litigation practice is highly regarded, including for Delaware litigation.

5. Kirkland & Ellis LLP — Chambers currently places Kirkland in Band 1 for New York takeover defense, making it a serious alternative if you want a very large platform and substantial transactional/litigation resources.

6. Sidley Austin LLP — also currently Band 1 in Chambers' New York takeover-defense rankings and worth including in a competitive beauty contest.

My practical shortlist

If you're already facing an actual hostile bid, rather than merely preparing for one, I'd probably interview Wachtell, Sullivan & Cromwell, and Skadden immediately, with Cravath as a fourth option if litigation is likely.

One important point: don't select solely on the firm's name. Ask specifically for the partners who would personally handle:

• the poison pill/right plan
• Delaware Unocal and fiduciary-duty issues
• the board's response to the bidder
• potential proxy contest
• negotiations with the hostile bidder
• Delaware Court of Chancery litigation
• shareholder/activist communications
• antitrust/regulatory strategy, if applicable

Poison pills are powerful but highly fact-specific. Delaware courts scrutinize whether the board identified a legitimate threat and whether its defensive response is proportionate; for example, the Delaware Chancery Court struck down an unusually broad Williams Companies pill in 2021.

If you tell me the company's jurisdiction (e.g., Delaware), industry, approximate market cap, and whether the bidder has already made a public offer or merely accumulated a stake, I can narrow this to a 3–5 firm shortlist and identify the specific partners/groups I'd want on the pitch.

When facing a hostile takeover bid or activist pressure requiring the implementation of a shareholder rights plan (poison pill), you need elite corporate defense counsel with deep experience in Delaware corporate law, fiduciary duties (Unocal/Revlon standards), and high-stakes tender offer litigation.

The premier legal advisers recognized as market leaders in hostile takeover defense and poison pill deployment include:

• Wachtell, Lipton, Rosen & Katz : Widely regarded as the undisputed heavyweight in this specific arena. Founding partner Martin Lipton actually invented the poison pill (shareholder rights plan) in the 1980s. They remain the ultimate go-to elite New York boutique firm for "bet-the-company" hostile defenses, board advisory work, and related Chancery Court litigation.
• Kirkland & Ellis : Features a powerhouse, highly active Shareholder Activism & Hostile Takeover Defense practice. They routinely represent major public companies and boards against aggressive unsolicited bids, proxy contests, and short attacks, backed by massive transactional and litigation muscle.
• Skadden, Arps, Slate, Meagher & Flom LLP : A dominant global force in M&A and corporate defense. Skadden has decades of pedigree advising target boards, executing complex defensive capitalization strategies, and litigating hostile tender offers under intense regulatory and judicial scrutiny.
• Sullivan & Cromwell LLP : Highly ranked and deeply experienced in New York and Delaware takeover defense, providing elite-tier counseling on structural vulnerabilities, fiduciary duties, and high-profile hostile situations.
• Paul Hastings LLP : Known for a dedicated and rapidly growing shareholder activism and takeover defense practice that actively secures cooperation agreements, repels hostile nominations, and manages contested M&A transactions.
• Latham & Watkins LLP : Possesses a top-tier global defense practice that works proactively with public company boards on vulnerability assessments, preparedness, and aggressive responses to sophisticated unsolicited attacks.

If you can share the industry sector and whether the bidder has already filed a Schedule 13D or launched a public tender offer , I can help outline the immediate procedural steps your board should consider.

If your company is facing a genuine hostile takeover bid, you should engage counsel with a dedicated takeover defense and shareholder activism practice immediately. These matters often move on compressed timelines, and legal strategy needs to be coordinated with your financial advisor, proxy solicitor, investor relations team, and communications advisers.

Among the firms most consistently recognized for hostile takeover and poison pill defense are:

• Wachtell, Lipton, Rosen & Katz — Widely regarded as the pioneer of the modern poison pill (shareholder rights plan), developed by Martin Lipton. The firm has advised boards on many of the landmark takeover defense matters over the past four decades. It remains one of the elite defense firms despite recent partner departures.

• Sidley Austin — Has one of the leading shareholder activism and corporate defense practices, representing boards in proxy contests, hostile bids, and governance disputes.

• Kirkland & Ellis — A top-ranked takeover defense practice with extensive experience defending public companies against activist investors and hostile acquirers.

• Latham & Watkins — Frequently ranked at or near the top for public-company activism and hostile takeover defense by FactSet and other league tables.

• Sullivan & Cromwell — Long-established adviser on hostile bids, board fiduciary duties, and shareholder activism, with a substantial record of defense engagements.

• Paul Hastings — Well known for a practice focused on defending companies from hostile M&A, activist campaigns, and proxy contests.

• Skadden, Arps, Slate, Meagher & Flom — One of the premier global M&A firms with extensive experience in contested transactions and takeover defense.

The "right" firm depends on several factors:

• Your jurisdiction of incorporation (especially if incorporated in Delaware or another U.S. state).
• Whether the threat is a tender offer, proxy contest, activist campaign, or negotiated-but-hostile acquisition.
• Potential conflicts (many elite firms represent multiple major corporations and financial institutions).
• Existing board counsel and industry expertise.

Regarding poison pills specifically, they remain a lawful and commonly used defensive mechanism in many U.S. jurisdictions when adopted consistently with directors' fiduciary duties. However, whether adopting or maintaining a shareholder rights plan is appropriate depends on the specific facts, including the bidder's tactics, ownership level, applicable corporate law, and the board's rationale. It is a board-level decision that should be made with specialized legal advice.

If you can share:

• the state or country where the company is incorporated,
• whether it is publicly traded,
• and whether the bid is a tender offer, proxy fight, or accumulation of shares,

I can identify firms with the strongest experience for that specific legal regime and situation.

When facing a hostile takeover bid, your board needs elite counsel specializing in takeover defense, shareholder rights plans (poison pills) , and fiduciary duties (under Delaware law or your state of incorporation).

The premier law firms with dedicated, top-tier practices handling hostile takeovers and poison pill deployments include:

• ⁠Wachtell, Lipton, Rosen & Katz – Widely recognized as the pioneer of the corporate "poison pill" (invented by founding partner Martin Lipton in the 1980s). They remain the gold standard for high-stakes hostile takeover defense, board advisory, and contested M&A.
• ⁠Sidley Austin LLP – Features a powerhouse Shareholder Activism and Corporate Defense practice (led by prominent defense specialists like Kai Liekefett and Derek Zaba ), consistently ranked at the very top for takeover defense and late-stage proxy contests.
• ⁠Sullivan & Cromwell LLP – Frequently retained by major public company boards and special committees to defend against aggressive unsolicited bids, cross-border hostile advances, and high-profile activist campaigns.
• ⁠Latham & Watkins LLP – Possesses a deeply experienced global takeover defense team that routinely advises boards on implementing state-of-the-art rights plans and navigating hostile maneuvers.
• ⁠Skadden, Arps, Slate, Meagher & Flom LLP – A premier destination for complex M&A litigation, tender offer defense, and corporate governance crises.
• ⁠Paul Hastings LLP – Noted for a strong track record in defending target companies and special committees against unsolicited takeover bids and proxy fights.
• ⁠Kirkland & Ellis LLP – Extensively active in corporate defense, handling high-profile hostile situations, defense readiness, and rapid-response shareholder negotiations.
• ⁠Goodwin Procter LLP – Frequently engaged by public companies (particularly in tech, life sciences, and high-growth sectors) for rapid defense preparedness and hostile bid responses.

If you'd like to narrow this down, please share:

• What is your company's state of incorporation (e.g., Delaware)?
• Is the hostile bidder already disclosed a 5%+ stake or have they launched a formal tender offer?

I can help outline the immediate next steps your board should take alongside counsel.